# Gavreto

NDC: 71332-006
Generic name: Pralsetinib
Labeler / Manufacturer: Rigel Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20240624

FDA application: NDA213721

## Active ingredients

- PRALSETINIB: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71332-006"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71332-006
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=16edd46e-28b8-f06d-e063-6394a90ae31b